The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Karpechkin M.O.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Health of Russia

Davydov D.V.

Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center

Morozova N.B.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center

Vorontsova M.S.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center

Tumor models in cancer research

Authors:

Karpechkin M.O., Davydov D.V., Morozova N.B., Vorontsova M.S.

More about the authors

Journal: P.A. Herzen Journal of Oncology. 2024;13(4): 72‑76

DOI: 10.17116/onkolog20241304172

Read: 1101 times

Download PDF (RU)
Contact the author
Table of contents

TUMOR MODELS IN CANCER RESEARCH
TUMOR MODELS IN CANCER RESEARCH

To cite this article:

Karpechkin MO, Davydov DV, Morozova NB, Vorontsova MS. Tumor models in cancer research. P.A. Herzen Journal of Oncology. 2024;13(4):72‑76. (In Russ.)
https://doi.org/10.17116/onkolog20241304172

Подписка 2026 Онкология. Журнал им. П.А. Герцена (P.A. Herzen Journal of Oncology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Dyna­mics of the main indi­cators of medi­cal care to the popu­lation of the Russian Fede­ration for the period 1993—2023 in the “Oncology” profile. P.A. Herzen Journal of Onco­logy. 2025;(3):71-77
New analgesics in onco­logy. Tafa­lgin employed as an alte­rnative to opioid analgesics. P.A. Herzen Journal of Onco­logy. 2025;(5):73-77
Primary outcomes after major anatomical liver rese­ctions in infa­nts at the National Children’s Medi­cal Center. Piro­gov Russian Journal of Surgery. 2025;(4):86-94
Approaches to the digi­tization of clinical guidelines. Medi­cal Technologies. Asse­ssment and Choice. 2025;(2):39-47
A clinical case of osteonecrosis of the jaw in an onco­logy patient that occu­rred after periodontal surgery. Russian Journal of Stomatology. 2025;(4):75-79
The role of outpatient clinics in the timely dete­ction of an onco­logical pathology in pregnant women. Russian Journal of Preventive Medi­cine. 2025;(12):31-34
Abstract:

According to statistics, cancer incidence is coming out on top in the world. Despite the fact that various types of tumors have been known for a relatively long time, currently science is far from a thorough understanding of carcinogenesis, and therefore from a complete cure for tumors. Experiments are constantly being conducted to develop not only new treatment methods, but also medicines. All these experiments are based on tumor models. This article presents the main tumor models used in oncology.

Keywords:

oncology
tumor model
mouse model
in vivo
in vitro

Authors:

Karpechkin M.O.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Health of Russia

Davydov D.V.

Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center

Morozova N.B.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center

Vorontsova M.S.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center

Received:

29.05.2024

Accepted:

13.06.2024

Close metadata

References:

  1. Kaprin AD, Starinskii VV, Shakhzadova AO, eds. The state of cancer care for the Russian population in 2022. M.: MNIOI im. P.A. Gertsena — filial FGBU «NMITs radiologii» Minzdrava Rossii; 2023. (In Russ.).
  2. Zhukova IV, Kolpak EP. Mathematical models of a malignant tumor. Bulletin of St. Petersburg University. Applied Mathematics. Computer Science. Management processes. 2014;(3):5-18. (In Russ.).
  3. Kitaeva KV, Rizvanov AA, Solov’eva VV. Modern methods of preclinical anticancer drug screening using test systems based on cell cultures. Scientific Notes of Kazan University. The Natural Sciences Series. 2021;163(2):155-176. (In Russ.). https://doi.org/10.26907/2542-064x.2021.2.155-176
  4. Mingaleeva RN, Solov’eva VV, Blatt NL, Rizvanov AA. Application of cell and tissue cultures for screening of antitumor drugs in vitro. Cell Transplantation and Tissue Engineering. 2013;8(2):20-28. (In Russ.).
  5. Uchida Y, Tanaka S, Aihara A, Adikrisna R, Yoshitake K, Matsumura S, Mitsunori Y, Murakata A, Noguchi N, Irie T, et al. Analogy between sphere forming ability and stemness of human hepatoma cells. Oncol Rep. 2010;24(5):1147-1151. https://doi.org/10.3892/or_00000966
  6. Chen HC. Boyden chamber assay. Methods Mol Biol. 2005;294:15-22.  https://doi.org/10.1385/1-59259-860-9:015
  7. Mehta P, Rahman Z, Ten Dijke P, Boukany PE. Microfluidics meets 3D cancer cell migration. Trends Cancer. 2022;8(8):683-697.  https://doi.org/10.1016/j.trecan.2022.03.006
  8. Kholodenko RV, Kholodenko IV, Doronin II. Tumor models in the study of oncological diseases. Immunology. 2013;(5):282-286. (In Russ.).
  9. Katt ME, Placone AL, Wong AD, Xu ZS, Searson PC. In vitro tumor models: advantages, disadvantages, variables, and selecting the right platform. Front Bioeng Biotechnol. 2016;4:12.  https://doi.org/10.3389/fbioe.2016.00012
  10. Bokova UA, Tret’yakova MS, Shchegoleva AA, Denisov EV. Mobile in vivo systems for research in oncology. Advances in Molecular Oncology. 2023;10(2):8-16. (In Russ.). https://doi.org/10.17650/2313-805x-2023-10-2-8-16
  11. Souto EP, Dobrolecki LE, Villanueva H, Sikora AG, Lewis MT. In vivo modeling of human breast cancer using cell line and patient-derived xenografts. J Mammary Gland Biol Neoplasia. 2022;27(2):211-230.  https://doi.org/10.1007/s10911-022-09520-y
  12. Bolotskikh LA, Karkishchenko VN, Karkishchenko NN, Semenov KhKh, Kasinskaya NV, Kapanadze GD, Revyakin AO, Matveenko EL. Creation of laboratory animals of SPF status as the basis of experimental medicine. Biomedicine. 2013;(4):158-163. (In Russ.).
  13. Sengupta P. The laboratory rat: relating its age with human’s. Int J Prev Med. 2013;4(6):624-630. 
  14. Gaidai EA, Gaidai DS. Genetic diversity of experimental mice and rats: history of origin, methods of production and control. Laboratory Animals for Scientific Research. 2019;(4). (In Russ.). https://doi.org/10/29926/2618723X-2019-04-09
  15. Treshchalina EM. Immunodeficient Balb/c nude mice and modeling of various tumor growth variants for preclinical studies. Russian Biotherapeutic Journal. 2017;16(3):6-13. (In Russ.). https://doi.org/10.17650/1726-9784-2017-16-3-6-13
  16. Xia X, Li H, Satheesan S, Zhou J, Rossi JJ. Humanized NOD/SCID/IL2rγnull (hu-NSG) mouse model for HIV replication and latency studies. J Vis Exp. 2019;(143):10.3791/58255. https://doi.org/10.3791/58255
  17. Nekhaeva TL, Chernov AN, Toropova YaG, Galagudza MM, Baldueva IA. A variety of tumor models for testing the antitumor activity of substances in mice. Issues of Oncology. 2020;66(4):353-363. (In Russ.).
  18. Klein G, Klein E. The transformation of a solid transplantable mouse carcinoma into an «ascites tumor». Cancer Res. 1951;11(6):466-469. 
  19. Timofeeva NYu, Bubnova NV, Struchko GYu, Kostrova OYu, Stomenskaya IS. Methods of experimental modeling of metastasis. Biomedicine. 2021;17(4):44-49. (In Russ.). https://doi.org/10.33647/2074-5982-17-4-44-49
  20. Scholz CC, Berger DP, Winterhalter BR, Henss H, Fiebig HH. Correlation of drug response in patients and in the clonogenic assay with solid human tumour xenografts. Eur J Cancer. 1990;26(8):901-905.  https://doi.org/10.1016/0277-5379(90)90196-z
  21. Kiblitskaya AA, Maksimov AYu, Goncharova AS, Nepomnyashchaya EM, Zlatnik EYu, Egorov GYu, Lukbanova EA, Zaikina EV, Volkova AV. Options for creating heterotopic and orthotopic PDX models of human colorectal cancer. Bulletin of Siberian Medicine. 2022;21(3):50-58. (In Russ.). https://doi.org/10.20538/1682-0363-2022-3-50-58
  22. Legrand N, Weijer K, Spits H. Experimental models to study development and function of the human immune system in vivo. J Immunol. 2006;176(4):2053-2058. https://doi.org/10.4049/jimmunol.176.4.2053
  23. Gudratov NO. Linear mice: advantages and disadvantages. Biomedicine. 2004;(4):40-42. (In Russ.).
  24. Kellar A, Egan C, Morris D. Preclinical murine models for lung cancer: clinical trial applications. Biomed Res Int. 2015;2015:621324. https://doi.org/10.1155/2015/621324
  25. Evans JP, Suttona PA, Winiarski BK. Fenwick SW, Malik HZ, Vimalachandran D, Tweedle EM, Costello E, Palmer DH, Park BK, et al. From mice to men: murine models of colorectal cancer for use in translational research. Crit Rev Oncol Hematol. 2016;98:94-105.  https://doi.org/10.1016/j.critrevonc.2015.10.009
  26. Stukov AN, Vershinina SF, Kozyavin NA, Semiglazova TYu, Filatova LV, Latipova DKh, Ivantsov AO, Bespalov VG, Semenov AP, Belyaeva OA, et al. Study of lomustin activity in HER2-positive breast cancer in FVB/N transgenic HER2 mice. Siberian Journal of Oncology. 2019;18(5):54-60. (In Russ.). https://doi.org/10.21294/1814-4861-2019-18-5-54-60
  27. Dutt A, Wong KK. Mouse models of lung cancer. Clin Cancer Res. 2006;12(14 Pt. 2):4396s-4402s. https://doi.org/10.1158/1078-0432.CCR-06-0414
  28. Kemp CJ. Animal models of chemical carcinogenesis: driving breakthroughs in cancer research for 100 years. Cold Spring Harb Protoc. 2015;2015(10):865-874.  https://doi.org/10.1101/pdb.top069906
  29. Kasala ER, Bodduluru LN, Barua CC. Benzo(a)pyrene induced lung cancer: role of dietary phytochemicals in chemoprevention. Pharmacol Rep. 2015;67(5):996-1009. https://doi.org/10.1016/j.pharep.2015.03.004
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.